The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,437.87 firm fixed-price delivery order, awarded on December 26, 2024 with a completion date of December 27, 2024, is for the supply of 100 units of the drug Vyvanse 10 mg capsule. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is a for-profit organization that has been registered in the System for Award Management (SAM.gov) since 2002 and plays a critical role in supplying medical products to federal government agencies, particularly the DLA and the Department of Justice Federal Bureau of Investigation.
Generated 3/27/25, 9:52 AM